Onyx Healthcare (ROCO:6569) Beneish M-Score: -2.65 (As of Jul. 12, 2026)


ROCO:6569 Onyx Healthcare Inc ROCO:6569
75 GF Score
Price NT$106.50
GF Value NT$121.39
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Onyx Healthcare Beneish M-Score?

Onyx Healthcare ROCO:6569 75 Beneish M-Score is -2.65 as of Jul. 12, 2026. GuruFocus rates ROCO:6569 with a GF Score™ of 75/100 and a GF Value™ of NT$121.39 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 630 Healthcare Providers & Services companies, Onyx Healthcare ranks better than 55.56% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.65 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Onyx Healthcare's Beneish M-Score or its related term are showing as below:

ROCO:6569' s Beneish M-Score Range Over the Past 10 Years
Min: -3   Med: -2.24   Max: 3.4
Current: -2.65

During the past 13 years, the highest Beneish M-Score of Onyx Healthcare was 3.40. The lowest was -3.00. And the median was -2.24.


Onyx Healthcare Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Onyx Healthcare's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onyx Healthcare Beneish M-Score Chart

Onyx Healthcare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.79 -1.81 -3.00 -2.29 -2.65

Onyx Healthcare Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.29 -1.88 -2.29 -2.26 -2.65

ROCO:6569 vs VEEV, BTSG, TEM: Beneish M-Score Comparison

For the Health Information Services subindustry, Onyx Healthcare's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onyx Healthcare Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Onyx Healthcare's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Onyx Healthcare's Beneish M-Score falls into.


ROCO:6569
75GF Score
Onyx Healthcare Inc ROCO:6569
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onyx Healthcare Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Onyx Healthcare for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8285+0.528 * 1.1123+0.404 * 1.0167+0.892 * 1.058+0.115 * 0.9572
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0359+4.679 * -0.023054-0.327 * 1.0468
=-2.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was NT$169 Mil.
Revenue was 315.741 + 330.137 + 357.469 + 309.941 = NT$1,313 Mil.
Gross Profit was 117.15 + 99.684 + 124.677 + 92.506 = NT$434 Mil.
Total Current Assets was NT$834 Mil.
Total Assets was NT$2,154 Mil.
Property, Plant and Equipment(Net PPE) was NT$379 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$22 Mil.
Selling, General, & Admin. Expense(SGA) was NT$271 Mil.
Total Current Liabilities was NT$384 Mil.
Long-Term Debt & Capital Lease Obligation was NT$146 Mil.
Net Income was 46.514 + 34.072 + 24.153 + 7.394 = NT$112 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0 Mil.
Cash Flow from Operations was 28.33 + 66.189 + 24.564 + 42.701 = NT$162 Mil.
Total Receivables was NT$193 Mil.
Revenue was 382.565 + 284.008 + 299.338 + 275.34 = NT$1,241 Mil.
Gross Profit was 148.314 + 88.936 + 104.983 + 114.042 = NT$456 Mil.
Total Current Assets was NT$825 Mil.
Total Assets was NT$2,106 Mil.
Property, Plant and Equipment(Net PPE) was NT$377 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$21 Mil.
Selling, General, & Admin. Expense(SGA) was NT$247 Mil.
Total Current Liabilities was NT$339 Mil.
Long-Term Debt & Capital Lease Obligation was NT$157 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(169.133 / 1313.288) / (192.946 / 1241.251)
=0.128786 / 0.155445
=0.8285

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(456.275 / 1241.251) / (434.017 / 1313.288)
=0.367593 / 0.330481
=1.1123

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (834.041 + 379.297) / 2153.687) / (1 - (824.607 + 377.119) / 2106.193)
=0.436623 / 0.429432
=1.0167

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1313.288 / 1241.251
=1.058

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(20.704 / (20.704 + 377.119)) / (21.809 / (21.809 + 379.297))
=0.052043 / 0.054372
=0.9572

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(271.234 / 1313.288) / (247.471 / 1241.251)
=0.20653 / 0.199372
=1.0359

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((146.119 + 384.249) / 2153.687) / ((156.606 + 338.864) / 2106.193)
=0.24626 / 0.235244
=1.0468

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(112.133 - 0 - 161.784) / 2153.687
=-0.023054

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Onyx Healthcare has a M-score of -2.65 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.65 mean?
Onyx Healthcare (ROCO:6569) has a Beneish M-Score of -2.65 as of Jul. 12, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Onyx Healthcare and its competitors. According to the industry distribution chart, Onyx Healthcare ranks #280 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 44.4%.
Is Onyx Healthcare's Beneish M-Score too high?
Onyx Healthcare's current Beneish M-Score is -2.65. Based on the distribution chart, Onyx Healthcare ranks #280 out of 630 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Onyx Healthcare has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Onyx Healthcare's Beneish M-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Onyx Healthcare ranks #280 out of 630 companies for Beneish M-Score. This puts Onyx Healthcare in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Onyx Healthcare and its competitors. Onyx Healthcare's current Beneish M-Score is -2.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Onyx Healthcare (ROCO:6569) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$121.39, compared to a current price of NT$106.50 — trading 12.3% below its estimated fair value. The current Beneish M-Score is -2.65. Onyx Healthcare's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Onyx Healthcare (ROCO:6569), the current Beneish M-Score is -2.65 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onyx Healthcare (ROCO:6569) Overvalued in 2026?

Based on GuruFocus' analysis, Onyx Healthcare stock appears to be undervalued. The current stock price of NT$106.50 is trading 12.3% below its estimated GF Value™ of NT$121.39. GuruFocus considers Onyx Healthcare to be Modestly Undervalued.

Key valuation signals for ROCO:6569:

  • Beneish M-Score: -2.65
  • GF Value™: NT$121.39 vs. price of NT$106.50 (12.3% below fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6569 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Onyx Healthcare Business Description

Address No. 135, Lane 235, Baoqiao Road, 4th Floor, Xindian District, New Taipei, TWN, 231028
Onyx Healthcare Inc is engaged in designing, manufacturing, and trading of medical computers and peripherals. The company provides medical products such as AI Ready Medical PC and Tablet, Medical PC & Monitor for Digital OR (ACCEL), Telemedicine, Medical Cart Computer(Venus), Medical Power Panel PC (Mini Venus), Power Bank (UPower), Battery Management System (ORION), Mobile Medical Tablet (MD), Professional Medical All in One PC (ZEUS), etc. It operates in Taiwan, the United States, Europe, and Other countries and generates maximum revenue from Taiwan.
75GF Score

Get the complete analysis for ROCO:6569

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$106.50
Price
NT$121.39
GF Value